HS
Publicaties op Oncologisch.com
Durvalumab versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCG...
Cemiplimab in recurrent cervical cancer: Final analysis of totale overleving in the phase III EMPOWER-Cervical 1/GOG-...
Cemiplimab bij recidief cervixcarcinoom: PROs EMPOWER-Cervical 1